INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 72 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $386,000 | +21.0% | 324,784 | +16.2% | 0.05% | +18.6% |
Q1 2022 | $319,000 | +3.9% | 279,605 | +211.1% | 0.04% | +38.7% |
Q3 2021 | $307,000 | -52.8% | 89,878 | -58.7% | 0.03% | -57.5% |
Q2 2021 | $651,000 | -15.6% | 217,687 | -23.4% | 0.07% | +69.8% |
Q3 2018 | $771,000 | +39.2% | 284,354 | -1.9% | 0.04% | +59.3% |
Q2 2018 | $554,000 | -12.8% | 289,854 | -4.1% | 0.03% | -20.6% |
Q1 2018 | $635,000 | +2167.9% | 302,154 | +2112.9% | 0.03% | +1600.0% |
Q4 2017 | $28,000 | -89.7% | 13,654 | -29.8% | 0.00% | -81.8% |
Q1 2015 | $272,000 | – | 19,446 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |